The Blue Pill and Drugmakers: A Risky Venture ?

The storied success of copyright’s flagship drug has undeniably influenced the healthcare landscape. However, investing in companies heavily dependent on copycat drugs and the diminishing patent protection surrounding this iconic medication presents a significant degree of danger. While leading p

read more